Active ingredientNystatinCat. No. P-N101-001CAS 1400-61-9Family · Pharmaceutical analytical standards
Nystatin
The first antifungal of the polyene macrolide class, produced by the bacterium Streptomyces noursei and discovered in 1950 by Rachel Fuller Brown and Elizabeth Lee Hazen; it is used for candidiasis of the skin, mouth and oesophagus. This family brings together the active ingredient and other impurities.
Did you know?The name honours the New York State Department of Health, where the two discoverers worked: the 13 million dollars earned from the patent were donated to a foundation to fund further research.
Go to the active ingredient →Active ingredientNystatinCat. No. P-N101-001CAS 1400-61-9
ImpurityCarboxylate Ion of NystatinCat. No. P-N101-002
Impurityiso-Nystatin A1Cat. No. P-N101-003CAS 2023830-46-6
ImpurityNystatin Impurity 1Cat. No. P-N101-004CAS 347-86-4
ImpurityNystatin Impurity 2Cat. No. P-N101-005CAS 34786-70-4
ImpurityNystatin A2Cat. No. P-N101-006CAS 65086-32-0
ImpurityNystatin A3Cat. No. P-N101-007CAS 62997-67-5
ImpurityNystatin Impurity 3Cat. No. P-N101-009CAS 96475-98-8No product matches your search.
EDQM standards 1
The official European Pharmacopoeia standards for this family.
Reference substanceNystatin CRSEDQM code N1400000Family NystatinNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.